Tianjin Chase Sun Pharmaceutical Co Ltd Free Cash Flow Generation Index
Tianjin Chase Sun Pharmaceutical Co Ltd free cash flow generation index. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥131.73 Million represents 1% of operating cash flow (CN¥153.30 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Free cash flow generation index of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. Historical FCF Generation Index trend for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. See financial flexibility index of Tianjin Chase Sun Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
Tianjin Chase Sun Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2006–2024)
Tianjin Chase Sun Pharmaceutical Co Ltd free cash flow generation index by year from 2006 to 2024. Year-by-year Free Cash Flow Generation Index for Tianjin Chase Sun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Tianjin Chase Sun Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥659.12 Million | CN¥852.24 Million | CN¥193.12 Million | ▲ +0.0% |
| 2023 | 0.77x | CN¥1.18 Billion | CN¥1.53 Billion | CN¥347.12 Million | ▲ +2411.9% |
| 2022 | -0.03x | CN¥-24.93 Million | CN¥745.35 Million | CN¥770.27 Million | ▲ +95.4% |
| 2021 | -0.73x | CN¥-285.85 Million | CN¥391.60 Million | CN¥677.45 Million | ▲ +60.9% |
| 2020 | -1.87x | CN¥-367.12 Million | CN¥196.66 Million | CN¥563.78 Million | ▼ -7.6% |
| 2019 | -1.73x | CN¥-374.91 Million | CN¥216.10 Million | CN¥591.01 Million | ▼ -821.8% |
| 2018 | 0.24x | CN¥93.30 Million | CN¥388.19 Million | CN¥294.89 Million | ▼ -50.3% |
| 2017 | 0.48x | CN¥359.04 Million | CN¥742.38 Million | CN¥383.34 Million | ▲ +565.7% |
| 2016 | 0.07x | CN¥32.55 Million | CN¥448.08 Million | CN¥415.52 Million | ▲ +108.6% |
| 2015 | -0.85x | CN¥-102.36 Million | CN¥121.00 Million | CN¥223.35 Million | ▼ -346.1% |
| 2014 | -0.19x | CN¥-28.43 Million | CN¥149.94 Million | CN¥178.37 Million | ▼ -174.8% |
| 2013 | 0.25x | CN¥36.40 Million | CN¥143.60 Million | CN¥107.20 Million | ▲ +156.0% |
| 2012 | -0.45x | CN¥-68.95 Million | CN¥152.21 Million | CN¥221.17 Million | ▲ +92.9% |
| 2011 | -6.37x | CN¥-226.87 Million | CN¥35.64 Million | CN¥262.51 Million | ▼ -341.7% |
| 2010 | -1.44x | CN¥-66.65 Million | CN¥46.25 Million | CN¥112.90 Million | ▼ -328.4% |
| 2009 | 0.63x | CN¥85.24 Million | CN¥135.06 Million | CN¥49.82 Million | ▲ +66.5% |
| 2008 | 0.38x | CN¥29.46 Million | CN¥77.74 Million | CN¥48.28 Million | ▼ -58.7% |
| 2007 | 0.92x | CN¥66.14 Million | CN¥72.01 Million | CN¥5.87 Million | ▲ +159.4% |
| 2006 | -1.54x | CN¥-1.89 Million | CN¥1.22 Million | CN¥3.12 Million | — |